IRS Filing and Payment Deadline Extended to July 15, 2020: What this Means for Individuals and Corporations

The Treasury Department and Internal Revenue Service have extended the federal income tax filing due from April 15, 2020, to July 15, 2020. The payment deadline was also extended to July 15, 2020.

The Treasury Department and Internal Revenue Service have extended the federal income tax filing due from April 15, 2020, to July 15, 2020. The payment deadline was also extended to July 15, 2020.

These steps are in an effort to provide special payment relief to individuals and businesses in response to the COVID-19 Outbreak. Income tax relief is expanded to all “persons,” including individuals, corporations, partnerships, trusts, and estates.

What This Means for Your Tax Filings

  • Taxpayers can defer federal income tax payments due on April 15, 2020, to July 15, 2020, without penalties and interest, regardless of the amount owed. This deferment applies to all income taxpayers, including individuals, trusts and estates, corporations and other non-corporate tax filers as well as those who pay self-employment tax.
  • Taxpayers do not need to file any additional forms or call the IRS to qualify for this automatic federal tax filing and payment relief.
  • Individual taxpayers who need additional time to file beyond the July 15 deadline, can request a filing extension by filing Form 4868. Businesses who need additional time must file Form 7004.
  • Relief applies to only federal income tax (including tax on self-employment income) payments due April 15, 2020.
  • This does not apply to state tax payments or deposits or payments of any other type of federal tax. State filing and payment deadlines vary and are not always the same as the federal filing deadline. The IRS urges taxpayers to check with their state tax agencies for those details or view deadlines here.  As of March 23, 2020, the New York State Tax Department has not extended the deadline to file personal income tax or other tax returns.
  • It is unclear whether relief will apply to gift or estate tax returns or payments.

More information can be found on the IRS Coronavirus Relief page.

I-9 “In-Person” Requirement Relaxed During Pandemic

During the 2020 coronavirus pandemic, DHS has relaxed the “in-person” review requirements associated with the Form I-9 process for certain employers on a remote working schedule. All other Form I-9 process rules remain in effect, meaning that remote-working employers must still complete Form I-9 within three (3) business days following an employee’s first day of work. You may review the official announcement on the DHS website.

Who does this affect?

Form I-9 in-person inspection rules are currently relaxed for any US employer who has converted to a total remote working schedule for all employees due to COVID-19. On the other hand, DHS states that “if there are employees physically present at a work location, no exceptions are being implemented at this time for in-person verification of identity and employment eligibility documentation for Form I-9.“ However, exceptions will also be made if newly-hired employees are subject to COVID-19 quarantine or lockdown protocols.

How should qualifying remote-working employers proceed?

Remote employees should be asked to complete Section 1 of Form I-9 and choose identity and work-authorization documents from List A/B/C.

Within three (3) business days of hire, remote employers must inspect the employee’s documents over video link, fax or email, etc. and complete Section 2. Employers must retain copies of any documents inspected remotely. Employers should enter “COVID-19” as the reason for the physical inspection delay in the Section 2 Additional Information field.

After normal operations resume and employees return to the office, employers have three (3) business days to physically examine the same documents previously reviewed electronically/remotely. Once the documents have been physically inspected, the employer should add “documents physically examined” with the date of inspection to the Section 2 additional information field on the Form I-9, or to section 3 as appropriate.

What else?

Remote-working employers who avail themselves of this option must be prepared to provide to DHS written documentation of their remote onboarding and telework policy.

DHS reminds employers that, as a general matter for remote workers (even before the pandemic), a company may designate anyone to serve as an “authorized representative” of the company for completion of Section 2, including the inspection of documents. The employer is liable for any violations in connection with the form or the verification process, including any violations in connection with the form or the verification process.

Finally, effective March 19, 2020, any employers who were served NOIs by DHS during the month of March 2020 and have not already responded will be granted an automatic extension for 60 days from the effective date. At the end of the 60-day extension period, DHS will determine if an additional extension will be granted.

How long are these relaxed rules effective?

The relaxed rules are effective immediately and will remain in place until Tuesday, May 19, 2020, or until the President ends the National Emergency Declaration, whichever comes first.

Gibney will be closely monitoring any proposed changes to I-9 policy or procedures and we will provide updates as needed.

If you have any questions about this alert, please contact your Gibney representative or email info@gibney.com.

The Federal Families First Coronavirus Act: What Employers Need to Know

As employers grapple with the effects of Covid-19 and federal, state, and local government mitigation efforts, many have had to make difficult decisions involving the shutdown of physical locations, employees unavailable due to closed schools and childcare, and employees suffering from the illness, caring for a loved one, or under a precautionary quarantine.

Among the most significant legal developments affecting employers is the federal Families First Coronavirus Response Act (H.R. 6201) (“FFCRA”) signed into law on March 18, 2020 and set to become effective on April 2, 2020.  The two sections of the FFCRA that will have the most direct impact on employers are Division C Emergency Family and Medical Leave Expansion Act and Division E Emergency Paid Sick Leave Act.

Emergency Family and Medical Leave Expansion Act

Under this emergency act, the definition of eligible employee is expanded to include any employee who has been employed for at least thirty calendar days.  Also, covered employers includes any employer with fewer than 500 employees.  While the FFCRA gives the Department of Labor authority to issue regulations to exclude certain healthcare providers, emergency responders, and employers with fewer than 50 employees if compliance will threaten their ability to continue as an ongoing concern, as of now, there is no statutory minimum number of employees for an eligible employer.

In order for an eligible employee to qualify for the expanded leave, the leave must be related to a public health emergency.  Specifically, the leave would be available to an employee unable to work or telework due to a need to care for a son or daughter under 18 years of age, if the school or daycare is closed, or a childcare provider is unavailable due to a public health emergency.  It should be noted that childcare provider is defined as a provider who receives compensation on a regular basis.

Significantly, the leave provided is paid, although the first 10 days of such leave may be unpaid.  An employee may elect to use available paid time off during this period; however, an employer may not require it. Thereafter, the paid leave must pay a minimum of two thirds of regular rate of pay for the hours the employee normally be scheduled to work up to a maximum of $200 per day and $10,000 in the aggregate.

The job protection provisions of the FMLA apply to leave covered by the FFCRA family leave expansion; however, an employer that employs fewer than 25 employees may be exempt under certain conditions; i.e., if the position no longer exists due to the public health emergency, the employer makes reasonable efforts to restore the employee to an equivalent position, and that the employer contacts the employee within one year of the end of the leave to let them know of an open equivalent position.  Finally, the law excludes employers from civil liability in an employee initiated suit if the employer did not employ 50 or more workers for each working day during 20 or more calendar workweeks in the preceding or current calendar year.

Emergency Paid Sick Leave Act

The emergency paid sick leave provisions of the FFCRA also apply to private employers with fewer than 500 employees.  Employees eligible to receive paid sick time are those unable to work or telework because the employee is:

  1. subject to a federal, state, or local quarantine or isolation order related to Covid-19;
  2. advised by their health care provider to self-quarantine due to concerns related to Covid-19;
  3. experiencing symptoms of Covid-19;
  4. caring for an individual subject to an order or advice under subparagraphs 1 and 2;
  5. caring for a son or daughter under 18 years of age, if their school or daycare is closed, or a childcare provider is unavailable due to Covid-19 precautions; or
  6. experiencing other similar conditions specified by the Secretary of Health and Human Services.

These employees are to be provided 80 hours of paid sick time if full-time.  Part-time employees are to be provided paid sick time for the average number of hours the employee works over a two week period.  Paid sick leave is available to employees regardless of how long they have been employed and employers may not require the requesting employee to search for or find a replacement.  The employer paid sick leave obligations are for their full hourly rate, but are capped at a per employee amount of $511 per day and $5,110 in the aggregate for leave based on 1 through 3 above.  For leaves based on 4 through 6 above, the employer needs to pay two-thirds of the hourly rate, up to a cap of $200 per day and $2,000 in the aggregate.

The law prohibits retaliation based on an employee’s request for such leave and applies the penalties (double damages and attorney’s fees) available under the Fair Labor Standards Act to such violations.  As with the expanded FMLA, the Department of Labor is allowed to enact regulations exempting certain employers, including employers with fewer than 50 employees whose viability may be jeopardized.

The Department of Labor should be issuing guidance in the coming days.  We will keep our clients updated on significant changes as the situation evolves and remain available to respond to specific employer questions.  We encourage all readers to consult with counsel if they have specific questions or concerns.

COVID-19: U.S. Travel Advisories and Suspension of Visa Services

As the world grapples with the COVID-19 pandemic, the U.S. and other countries are cautioning against travel,  imposing fast-breaking travel restrictions, and cancelling non-essential visa services at consulates abroad. Recent actions are highlighted below.

Travel Advisory – U.S. Citizens

  • The U.S. Department of State has issued a travel advisory  advising  U.S. citizens to avoid all international travel and recommending that U.S. citizens arrange for immediate return to the U.S. if they are able to do so.  The State Department is warning that U.S. citizens who chose to travel internationally may be forced to remain outside of the U.S. indefinitely.
  • The State Department has also authorized the departure of U.S. personnel and family members from its diplomatic and consular posts abroad if they are at higher risk if exposed to COVID-19.  Departure of personnel may limit the ability of U.S. Embassies and consulates to provide services to U.S. citizens who remain abroad.

Suspension of U.S. Visa Services

  • With increased travel restrictions, the Department of State also announced that it is suspending routine U.S. visa services in most countries worldwide and cancelling immigrant and nonimmigrant visa appointments effective March 18, 2020.  The Department of State aims to resume visa services as soon as possible, but cannot provide a specific date at this time. Please check the Embassy websites for the status of current operations and for information about the availability of emergency appointments.

Travel to the U.S.

  • Earlier this week, the U.S. and Canada announced a mutual agreement to close their shared border to non-essential travel. Official details regarding implementation have not been published as of March 19.
  • The Trump Administration has temporarily suspended travel to the U.S. for most foreign nationals traveling from Schengen Area countries in Europe, the U.K. and Ireland,  China and Iran.  Additional information is available on our Insights We expect more countries to face similar restrictions going forward and it is possible that the U.S. may determine to temporarily close its borders to all foreign national travelers in the near future.

Travel to Countries Outside the U.S.

Gibney is closely monitoring these developments.  Please contact a Gibney representative for additional information.

Online Safety: Avoiding Counterfeit COVID-19 Testing Kits

Almost as if on cue, as the United States ramps up testing and containment measures, US Customs and Border Protection (CBP) announced its first seizure of counterfeit COVID-19 test kits at the Los Angeles Airport International Mail Facility. The seizure took place on March 12 and involved vials which had been manifested as innocuous purified water vials. However, upon closer examination, the vials bore labels which included language identifying them as corona virus test kits.

It is unfortunate that the most trying of times still bring out the worst in people willing to risk public health and safety to make money trading on fear.  There are no magic beans and currently no publicly available test kit for the virus. Whether these tests were going to be peddled online or enter into the public health system is unknown. However, it is clear that vigilance is necessary to prevent counterfeit test kits and pharmaceuticals from entering the stream of commerce and use. Consumers should not be shocked at a seizure like this one. Counterfeit pharmaceutical products are an unfortunate development that impact all levels of society. And, admittedly, sometimes we may chuckle at the stories of counterfeit erectile dysfunction products, but these fall into the same category as counterfeit cough syrup, anti-malarials, cancer treatments and blood thinners (and the list goes on).  Counterfeit pharmaceuticals have deadly consequences wherever they are unleashed.

The fact that the seizure took place at an international mail facility should not come as a surprise. Producers and shippers based overseas have, for years, exploited low shipping rates and sheer volume of small parcels to overwhelm the system. We are fortunate to have CBP Officers at the ports, courier hubs and mail facilities dedicating their efforts to stem the flow of dangerous counterfeits entering the country. However, with the constant increase in e-commerce orders and fulfillment, there is also a part all of us can play in protecting the health and safety of our communities.

Best Practices for Protecting Against Counterfeit Pharmaceutical Products

With only a relatively small percentage of imported goods actually targeted and inspected, we have to do our part as well.

  • Be careful what you order. The FDA has a strong system in place to test and approve a variety of health related products. Do not fall for online panaceas and promises.
  • Check where the seller is located. A large percentage of seized counterfeit goods originate in China.  The old adage “Location, location, location” is very relevant.
  • Watch those prices. No one will be so altruistic as to offer goods for a miniscule percentage of cost or value.
  • Shop smart. Before you place an order for pharmaceuticals that are normally only available with a prescription, ask why on earth would they be available online without a doctor’s approval.

We all have a role to play in maintaining the integrity of health tools needed to combat this pandemic. Make smart choices to prevent counterfeits from impacting the health and safety of your community.

If you have any questions about this alert, please contact your Gibney representative or email info@gibney.com.

COVID-19 Measures: U.S. Travel Ban Expanded to U.K. and Ireland

The Trump Administration issued a Proclamation extending travel restrictions to travelers from the U.K. and Ireland.  The ban will take effect at 11:59 pm ET on Monday March 16, 2020.  Impacted travelers include most foreign nationals who have been physically present in the U.K. or Ireland at any point during the 14 day period prior to arrival in the U.S. A similar ban went into effect on Friday, March 13, 2020 at 11:59 pm ET for travelers who have been in Schengen Area countries at any point during the 14 days prior to their scheduled arrival in the U.S.

The U.K. and Ireland will join the growing list of travel impacted countries including Austria, Belgium, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Slovakia, Slovenia, Spain, Sweden, Switzerland, Iran and China.

It is likely that additional countries will be added to this list as the U.S. and the rest of the world grapples with the COVID-19 pandemic. All travelers should also expect other countries to impose restrictions, and should check foreign embassy websites and airline carriers before traveling.

WHO IS EXEMPTED FROM THE BAN?

The entry restrictions for the U.K., Ireland and Schengen Area countries do not apply to U.S. citizens, U.S. lawful permanent residents, immediate family members of U.S. citizens, and certain other individuals who are identified in the proclamation. Exempted individuals will arrive on flights that are directed to designated ports of entry to the U.S. and these travelers will undergo enhanced screening. Those who are allowed to enter the U.S. will be asked to self-quarantine for 14 days.

HOW LONG WILL THE BAN REMAIN IN EFFECT?

While news outlets have widely reported that the suspension will remain in effect for 30 days, the Presidential Proclamation announcing the Schengen Area ban does not specify a time period. Gibney is monitoring the implementation of these measures and will provide updates as they become available.

If you have any questions about this alert, please contact your Gibney representative or email info@gibney.com.

Visa Appointments at U.S. Embassy and Consulates in India Cancelled 

On March 13, 2020, the U.S. Department of State announced on its website that the U.S. Embassy and Consulates in India are cancelling all visa appointments scheduled on or after March 16, 2020 due to the COVID-19 pandemic. The U.S. Department of State has not provided a date by when they expect to resume regular consular operations.

Who is Impacted?

Any foreign nationals who have scheduled, or are in the process of scheduling, a visa appointment at a U.S. Embassy or Consulate in India.

Do Cancellations Apply to Both Immigrant and Nonimmigrant Visa Appointments?

Yes, the U.S. Embassy and Consulates in India are cancelling all nonimmigrant and immigrant visa appointments scheduled on or after March 16, 2020.

Will the Embassy Contact Each Visa Applicant with a New Appointment Date?

No, it will be the visa applicant’s responsibility to monitor the website of the U.S. Embassy and Consulates in India to find out when appointments will be made available again and schedule a new one.

If you are currently in India and had a U.S. visa appointment scheduled on or after March 16, 2020, please contact your Gibney representative immediately.

Foreign nationals who are in the U.S. and are planning on visiting India in the near future should contact their Gibney representative to discuss travel risks and visa/status renewal or extension options. If travel or visa appointments were cancelled, please be sure to notify your Gibney representative to ensure no other action is needed to maintain valid status in the U.S.

Background Information and Resources

More information on the U.S. Embassy and Consulates in India and their operations is available here.

If you have any questions about this alert, please contact your Gibney representative or email info@gibney.com.

The general information provided is not intended to serve as a source of legal advice for any purpose. Please contact your designated Gibney representative or immigration counsel for specific legal advice.

Counterfeits in the Age of COVID-19: Online Best Practices

As the COVID-19 pandemic spreads throughout the corners of the world, people rush to complete shopping and stock pantries and medicine cabinets by shopping online. In their haste and sometime desperation, individuals become easy targets for fraudsters and counterfeiters. Now more than ever offers stark examples of why counterfeiters always seek to profit from human misery and show no regard for the fragility of human life.

Online Best Practices for Protecting Against Counterfeit Products

Spend some time shopping for elusive hand sanitizer, gloves, disinfectant wipes and more and you will see quite clearly the manner in which counterfeiters seek to profit. Offering items that appear to be genuine while making spurious claims about curative properties is often a sign that the goods may not be what they appear to be.

Take a close look at the seller names. Do they appear to be an odd jumble of letter thrown together? Does the seller have a lack of selling history? Prices too low for a tight, shortage plagued market?  Product descriptions sound a little off or not quite in English? All signs you may be dealing with less than reputable merchants.

What about an unheard of site offering product at reasonable to slightly high prices? You attempt to order but after providing all you credit card and shipping information the site bombs out. Often a sign of a scam site that is more interested in obtaining data than providing product.

The golden rule of if it’s too good to be true, it likely isn’t still holds even in these difficult times. When personal health and safety are of the utmost concern, it pays to stick to the sites, brands and sellers you are familiar with and have a reputation of being responsible. Do not be fooled by counterfeiters who have no qualms about putting health and safety at risk. And remember, no matter how much a legitimate site claims to be policing third party sellers, the sheer volume can overwhelm those efforts.

It is important to be as vigilant about purchasing health related products as it is to prevent the spread of COVID-19.  Let’s be careful out there!

COVID-19 Measures: U.S. Expands Travel Ban to Include Europe

President Trump signed a Presidential Proclamation further limiting travel to the United States for foreign nationals traveling from several European countries.

WHO IS IMPACTED?

The Proclamation suspends entry to the United States of most foreign nationals who have been in Schengen Area countries at any point during the 14 days prior to their scheduled arrival in the United States.  The impacted countries include: Austria, Belgium, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Slovakia, Slovenia, Spain, Sweden, and Switzerland. The United Kingdom is not included in the restriction.

WHEN DOES THE BAN TAKE EFFECT?

The entry restrictions will go into effect on Friday, March 13, 2020 at 11:59 pm ET. The restriction will not apply to persons aboard flights scheduled to arrive in the U.S. that departed prior to 11:59 pm ET on March 13.

WHO IS EXEMPTED FROM THE BAN?

The entry restrictions do not apply to U.S. citizens, U.S. lawful permanent residents, immediate family members of U.S. citizens, and certain other individuals who are identified in the Proclamation. Those who are allowed to enter the U.S. after travel to Europe will likely be subject to quarantine measures and their flights may be directed to selected ports of entry, as yet to be named.

HOW LONG WILL THE BAN REMAIN IN EFFECT?

News outlets have widely reported that the suspension will remain in effect for 30 days. However, the Proclamation does not specify a time period. Gibney is monitoring the implementation of these measures and will provide updates as they become available.

Background Information and Resources

Information about all of the U.S.  travel restrictions associated with the coronavirus, including links to some general resources, is available here.

If you have any questions about this alert, please contact your Gibney representative or email info@gibney.com.

The general information provided is not intended to serve as a source of legal advice for any purpose. Please contact your designated Gibney representative or immigration counsel for specific legal advice.

SHOP Safe Act of 2020: Making E-Commerce Companies Liable for Counterfeits

The House of Representatives recently introduced the Stopping Harmful Offers on Platforms by Screening Against Fakes in E-commerce (SHOP Safe) Act of 2020. The bipartisan bill incentivizes e-commerce platforms to adopt best practices to reduce the presence of counterfeit products on their sites. E-commerce sites that fail to adhere to the steps would be held liable.

The SHOP SAFE Act would:

  • Establish contributory trademark liability for e-commerce platforms when a third-party sells counterfeit products and the platform does not follow certain best practices
  • Incentivize e-commerce platforms to establish best practices to vet sellers, remove counterfeit listings and monitor sellers
  • Require e-commerce platforms to take steps to prevent the continued sale of counterfeits by third-party sellers or be subject to contributory liability

10 Reasonable Steps in the SHOP Safe Act:

Steps for e-commerce platforms would include:

  1. Verify the third party seller’s identity, principal place of business and contact information
  2. Require the third-party seller to verify and attest to the authenticity of its goods
  3. Provide contractual requirements that the third-party sellers agrees not to sell, distribute or advertise counterfeit goods on the platform and consents to the jurisdiction of U.S. courts
  4. Clearly display the third party seller’s verified principal place of business, contact information and identity, including the country of origin for both the manufacturing and shipping goods
  5. Require the third party seller to use images that they own or have permission to use and that accurately depict the actual goods being sold
  6. Implement technology to screen goods before posting to prevent counterfeit sales
  7. Implement a timely takedown process for the removal of counterfeit listings
  8. Terminate any third-party seller that has engaged in more than three instances of counterfeit sales, distribution or advertising
  9. Screen and prevent third-party sellers from participating on the platform under a different seller identity or alias
  10. Provide the infringing third-party seller’s information to relevant law enforcement and, upon request, the trademark owner

What this Means for Brand Owners

There has been an increase in efforts to help prevent the sale of counterfeit goods that pose a threat to consumer health and safety.

More brands are increasingly transitioning from traditional brick and mortar to online retail. With that transition, we have seen a significant increase in the sale of counterfeits goods online. Combating counterfeit sales can be extremely timely and costly for brand owners.

While e-commerce platforms have started to implement policies to manage counterfeit sales, contributory liability puts the burden of responsibility on the both the counterfeit seller and the platform. If implemented, these practices will create an incentive for online retailers to be more diligent and proactive.

Gibney will continue to monitor developments on this issue.

Author
John Macaluso
Partner, Intellectual Property
jmacaluso@gibney.com